Trials / Unknown
UnknownNCT01337557
Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Hom, Milton M., OD, FAAO · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess if BEPREVE (bepotastine besilate ophthalmic solution) 1.5% will have an effect on contact lens wear in patients with contact lens intolerance due to allergic conjunctivitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bepotastine | 1.5% bid |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-09-01
- Completion
- 2011-11-01
- First posted
- 2011-04-19
- Last updated
- 2011-04-19
Source: ClinicalTrials.gov record NCT01337557. Inclusion in this directory is not an endorsement.